(MTX) MTU Aero Engines - Ratings and Ratios
Commercial Engines, Military Engines, Industrial Turbines, Spare Parts, MRO
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.62% |
| Yield on Cost 5y | 1.17% |
| Yield CAGR 5y | -12.68% |
| Payout Consistency | 94.0% |
| Payout Ratio | 12.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.4% |
| Value at Risk 5%th | 40.6% |
| Relative Tail Risk | -6.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.34 |
| Alpha | 6.17 |
| CAGR/Max DD | 0.65 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.497 |
| Beta | 0.284 |
| Beta Downside | 0.538 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.13% |
| Mean DD | 7.05% |
| Median DD | 4.04% |
Description: MTX MTU Aero Engines October 16, 2025
MTU Aero Engines AG (XETRA:MTX) designs, manufactures, markets and services commercial and military aircraft engines as well as aero-derivative gas turbines, operating globally from its headquarters in Munich, Germany.
The business is split into two distinct segments: (1) Original Equipment Manufacturing (OEM), which supplies engines for wide-body, narrow-body, regional, business jets and turboprops, plus military powerplants for fighters, helicopters and transport aircraft; and (2) Maintenance, Repair and Overhaul (MRO), which generates recurring revenue by servicing those engines and supplying spare parts.
Key recent metrics: FY 2023 revenue reached €13.5 bn, with the MRO segment contributing roughly 45 % of total earnings and delivering an adjusted EBIT margin of ~12 %; the order backlog stood at €23 bn, reflecting a healthy pipeline across both commercial and defense programs. The company’s exposure to rising defense budgets in Europe and the U.S., together with the ongoing recovery in commercial air travel, are primary macro drivers of demand.
Sector-level trends that materially affect MTU include the industry-wide shift toward higher-bypass ratio engines for fuel efficiency, the acceleration of fleet retirements post-pandemic, and the growing importance of digital MRO services that can boost utilization rates.
For a deeper quantitative assessment, you may want to explore MTX’s valuation metrics and peer comparisons on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.35b TTM) > 0 and > 6% of Revenue (6% = 732.1m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -1.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.69% (prev 12.01%; Δ 3.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 778.0m <= Net Income 1.35b (YES >=105%, WARN >=100%) |
| Net Debt (1.18b) to EBITDA (2.09b) ratio: 0.56 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (54.3m) change vs 12m ago -3.94% (target <= -2.0% for YES) |
| Gross Margin 19.06% (prev -3.93%; Δ 22.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 107.3% (prev 71.82%; Δ 35.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.0 (EBITDA TTM 2.09b / Interest Expense TTM 119.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.48
| (A) 0.16 = (Total Current Assets 6.79b - Total Current Liabilities 4.88b) / Total Assets 11.78b |
| (B) 0.28 = Retained Earnings (Balance) 3.32b / Total Assets 11.78b |
| (C) 0.15 = EBIT TTM 1.67b / Avg Total Assets 11.37b |
| (D) 0.49 = Book Value of Equity 3.85b / Total Liabilities 7.87b |
| Total Rating: 3.48 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.35
| 1. Piotroski 6.50pt |
| 2. FCF Yield 1.72% |
| 3. FCF Margin 2.82% |
| 4. Debt/Equity 0.64 |
| 5. Debt/Ebitda 0.56 |
| 6. ROIC - WACC (= 14.61)% |
| 7. RoE 37.87% |
| 8. Rev. Trend 45.85% |
| 9. EPS Trend 85.70% |
What is the price of MTX shares?
Over the past week, the price has changed by +0.48%, over one month by -6.83%, over three months by -7.03% and over the past year by +14.47%.
Is MTX a buy, sell or hold?
What are the forecasts/targets for the MTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 410.6 | 16.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 409.5 | 16% |
MTX Fundamental Data Overview November 27, 2025
Market Cap EUR = 18.84b (18.84b EUR * 1.0 EUR.EUR)
P/E Trailing = 22.6146
P/E Forward = 19.5313
P/S = 2.2286
P/B = 4.8705
P/EG = 1.2518
Beta = 0.966
Revenue TTM = 12.20b EUR
EBIT TTM = 1.67b EUR
EBITDA TTM = 2.09b EUR
Long Term Debt = 1.97b EUR (from longTermDebt, last quarter)
Short Term Debt = 288.0m EUR (from shortTermDebt, last quarter)
Debt = 2.45b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.18b EUR (from netDebt column, last quarter)
Enterprise Value = 20.02b EUR (18.84b + Debt 2.45b - CCE 1.27b)
Interest Coverage Ratio = 14.0 (Ebit TTM 1.67b / Interest Expense TTM 119.0m)
FCF Yield = 1.72% (FCF TTM 344.0m / Enterprise Value 20.02b)
FCF Margin = 2.82% (FCF TTM 344.0m / Revenue TTM 12.20b)
Net Margin = 11.06% (Net Income TTM 1.35b / Revenue TTM 12.20b)
Gross Margin = 19.06% ((Revenue TTM 12.20b - Cost of Revenue TTM 9.88b) / Revenue TTM)
Gross Margin QoQ = 22.39% (prev 17.53%)
Tobins Q-Ratio = 1.70 (Enterprise Value 20.02b / Total Assets 11.78b)
Interest Expense / Debt = 3.35% (Interest Expense 82.0m / Debt 2.45b)
Taxrate = 29.41% (240.0m / 816.0m)
NOPAT = 1.18b (EBIT 1.67b * (1 - 29.41%))
Current Ratio = 1.39 (Total Current Assets 6.79b / Total Current Liabilities 4.88b)
Debt / Equity = 0.64 (Debt 2.45b / totalStockholderEquity, last quarter 3.84b)
Debt / EBITDA = 0.56 (Net Debt 1.18b / EBITDA 2.09b)
Debt / FCF = 3.42 (Net Debt 1.18b / FCF TTM 344.0m)
Total Stockholder Equity = 3.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.45% (Net Income 1.35b / Total Assets 11.78b)
RoE = 37.87% (Net Income TTM 1.35b / Total Stockholder Equity 3.56b)
RoCE = 30.11% (EBIT 1.67b / Capital Employed (Equity 3.56b + L.T.Debt 1.97b))
RoIC = 21.13% (NOPAT 1.18b / Invested Capital 5.56b)
WACC = 6.52% (E(18.84b)/V(21.29b) * Re(7.06%) + D(2.45b)/V(21.29b) * Rd(3.35%) * (1-Tc(0.29)))
Discount Rate = 7.06% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.53%
[DCF Debug] Terminal Value 79.45% ; FCFE base≈408.4m ; Y1≈443.8m ; Y5≈556.0m
Fair Price DCF = 180.2 (DCF Value 9.69b / Shares Outstanding 53.8m; 5y FCF grow 9.84% → 3.0% )
EPS Correlation: 85.70 | EPS CAGR: 65.78% | SUE: 0.30 | # QB: 0
Revenue Correlation: 45.85 | Revenue CAGR: 46.21% | SUE: 2.32 | # QB: 1